市場調查報告書
商品編碼
1211025
吸入和鼻腔外包服務提供商的全球市場規模和預測:按產品、服務和地區分析,2022-2029 年Global Inhaled and Intranasal Products Contract Service Providers Market Size study & Forecast, by Product by Services and Regional Analysis, 2022-2029 |
2021 年全球吸入器和鼻腔產品合同服務提供商市場價值約為 22.1 億美元,在 2022-2029 年的預測期內健康增長率超過 8.5% 預計將增長
吸入和鼻用產品是專門設計的醫療器械,用於預防哮喘和控製過敏、花粉症和某些鼻部疾病。 服務提供商協議是在提供特定服務的一方與接受該服務的一方之間建立關係以提供專業服務以供考慮的協議。 對有效和先進的呼吸設備的認識不斷提高、老年人口不斷增加以及監管合規性的簡化是全球市場需求的主要驅動力。
慢性呼吸道疾病的增加是市場增長的驅動因素。 世界衛生組織 (WHO) 報告稱,呼吸道疾病每年導致約 300 萬人死亡(佔全球所有死亡人數的 6%),在低收入和中等收入國家,約 90% 的慢性阻塞性肺病死亡人數超過 70 歲。並且是第三大疾病死亡的主要原因。 據估計,大約有 2.62 億人患有哮喘,這種疾病經常影響兒童。 因此,這些因素與直接吸入和鼻腔產品合同服務提供商的增長有關。 此外,對先進技術開發的投資增加以及基於最新技術的霧化器的推出在預測年內提供了各種有利可圖的機會。 然而,在整個 2022-2029 年的預測期內,嚴格的產品審批政府法規限制了市場增長。
全球吸入器和鼻腔產品合同服務提供商市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於呼吸系統疾病的發病率增加、政府舉措的增加和多項政策的實施,亞太地區在收入方面佔據了市場主導地位。 另一方面,由於有利的保險報銷情況和市場空間中存在大量合同製造商等因素,預計北美在預測期內將以最高複合年增長率增長。
這項研究的目的是揭示近年來各個細分市場和國家/地區的市場規模,並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Inhaled and Intranasal Products Contract Service Providers Market is valued at approximately USD 2.21 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Inhaled and intranasal products is a specially designed medical device that is used for the prevention of asthma and the management of allergy, hayfever, and some nasal conditions. The contract service providers are contract regulates relations in the rendering of professional services between a party which offers the specified service and another the recipient thereof in exchange for a payment. The growing awareness of the effective and advanced respiratory devices, increase in geriatric population, and ease of regulatory compliance are the primary factors that are attributing towards the market demand across the globe.
The increasing incidences of chronic respiratory diseases is acting as a catalyzing factor for the growth of the market. The World Health Organization (WHO) reported that the respiratory disease infections as the third leading cause of mortality, which is accounting for around 3 million deaths year (or 6% of all fatalities worldwide), with nearly 90% of COPD fatalities occurring in individuals over 70 from low- and middle-income nations. Also, there are around 262 million patients were estimated to suffer from asthma, which commonly affects children. Thus, theses aforementioned factors are directly associated growth of the inhaled and intranasal products contract service providers. Moreover, rising investment in the development of advanced technology, as well as the rising launch of the latest technology-based nebulizers are presenting various lucrative opportunities over the forecasting years. However, stringent government regulations for the product approval are a restricting the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Inhaled and Intranasal Products Contract Service Providers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the increasing incidences of respiratory disorder, along with the rising government initiatives and implementation of several policies. Whereas, North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as the favorable reimbursement scenario, as well as presence of a large number of contract manufacturers in the market space.
Major market players included in this report are:
Lonza
Catalent Inc.
Kindeva Drug Delivery
Recipharm
Quotient Services
Hovione
Colep
Beximo Pharmaceuticals
DPT Laboratories
Orion
Recent Developments in the Market:
Global Inhaled and Intranasal Products Contract Service Providers Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Services, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Metered - dose Inhalers
Dry Powder Inhalers
Nebulizers
Others
By Services:
Quality Assurance
Regulatory Affair Services
Product Design & Development
Product Maintenance
Contract Manufacturing
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable